{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:27:20Z","timestamp":1781962040051,"version":"3.54.5"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/leu.2016.94","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T04:42:35Z","timestamp":1463460155000},"page":"1630-1631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reporting results for deep molecular responses in chronic myeloid leukemia"],"prefix":"10.1038","volume":"30","author":[{"given":"A A","family":"Morley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"BFleu201694_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/leu.2015.29","volume":"29","author":"NC Cross","year":"2015","unstructured":"Cross NC, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E et al. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia 2015; 29: 999\u20131003.","journal-title":"Leukemia"},{"key":"BFleu201694_CR2","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/leu.2015.93","volume":"29","author":"IP Ho-Wan","year":"2015","unstructured":"Ho-Wan IP, Chi-Chiu SO . Deep molecular response in chronic myelogenous leukemia: ensuring accuracy and consistency. Leukemia 2015; 29: 1620\u20131621.","journal-title":"Leukemia"},{"issue":"9","key":"BFleu201694_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/jclinpath-2015-203538","volume":"69","author":"Susan Latham","year":"2016","unstructured":"Latham S, Bartley PA, Budgen B, Ross DM, Hughes E, Branford S et al. BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemia. J Clin Pathol 2016; e-pub ahead of print 2 February 2016 doi:10.1136\/jclinpath-2015-203538.","journal-title":"Journal of Clinical Pathology"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201694","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:42:37Z","timestamp":1781916157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":3,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFleu201694"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.94","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"assertion":[{"value":"17 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author holds equity in Monoquant Pty Ltd, which holds a patent related to sequencing of BCR-ABL1.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}